2008•PubMedRequires access

[A case of elderly non-small cell lung cancer effectively treated by combined chemotherapy of gemcitabine and S-1].

Kyoichi Kaira, Noriaki Sunaga, Noriko Yanagitani, Hisao Imai, Mitsuyoshi Utsugi, Yasuo Shimizu, Tadayoshi Kawata, Takeshi Hisada, Kimihiro Shimizu, Takafumi Tsuchiya, Tamotsu Ishizuka, Masatomo Mori

Open publisher page 0 citations

Abstract

The patient was an 86-year-old female who suffered from advanced non-small cell-lung cancer (cT4N3M1, Stage IV). She was treated with combined chemotherapy of gemcitabine and S-1 as first-line therapy. This regimen was performed as a phase I trial for elderly patients with advanced non-small cell lung cancer. The treatment assessment was evaluated as partial response. No toxic events were observed due to this therapy, so she was treated as an outpatient. She was considered to have good quality of life.

About this research paper

What this paper is about

The patient was an 86-year-old female who suffered from advanced non-small cell-lung cancer (cT4N3M1, Stage IV). She was treated with combined chemotherapy of gemcitabine and S-1 as first-line therapy. This regimen was performed as a phase I trial for elderly patients with advanced non-small cell lung cancer. The treatment assessment was evaluated as partial response. No toxic events were observed due to this therapy, so she was treated as an outpatient. She was considered to have good quality of life.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The patient was an 86-year-old female who suffered from advanced non-small cell-lung cancer (cT4N3M1, Stage IV). She was treated with combined chemotherapy of gemcitabine and S-1 as first-line therapy. This regimen was performed as a phase I trial for elderly patients with advanced non-small cell lung cancer. The treatment assessment was evaluated as partial response. No toxic events were observed due to this therapy, so she was treated as an outpatient. She was considered to have good quality of life.

Key concepts: Gemcitabine, Medicine, Lung cancer, Regimen, Chemotherapy, Oncology, Internal medicine, Quality of life (healthcare)

Back to paper searchBrowse research topicsOriginal source
[A case of elderly non-small cell lung cancer effectively treated by combined chemotherapy of gemcitabine and S-1]. — Research Paper | ScholarLens